抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | DM4 | 796073-69-3 | C38H54ClN3O10S |
|
—— | Estra-1,3,5(10)-triene-3,17-diol(17b)-, 17-cyclopentanepropanoate | 313-06-4 | C26H36O3 |
|
—— | FSRYAR | 725715-18-4 | C36H54N12O9 |
|
—— | chimmitecan | 185425-25-6 | C23H20N2O5 |
|
—— | N-(2-(4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl)-1,1-dimethylethyl)methanesulfonamide | 642473-62-9 | C18H25N5O3S |
|
—— | Pictilisib dimesylate | 957054-33-0 | 2CH4O3S*C23H27N7O3S2 |
|
—— | N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline hydrochloride | 1352610-25-3 | C22H18FN7*ClH |
|
—— | O,O'-Diisobutyroyl-thiamindisulfid | 3286-46-2 | C32H46N8O6S2 |
|
—— | lefamulin acetate | 1350636-82-6 | C2H4O2*C28H45NO5S |
|
—— | benidipine hydrochloride | 91599-74-5 | C28H31N3O6*ClH |
|
—— | bromfenac sodium | 91714-93-1 | C15H11BrNO3*Na |
|
—— | 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide | 342577-38-2 | C17H24F3N3O3S |
|
—— | (1r,4r)-4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl 2-aminoacetate | 908115-27-5 | C25H30F3N5O4 |
|
—— | E7016 | 902128-92-1 | C20H19N3O3 |
|
—— | cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid | 471905-41-6 | C21H21ClF2O4S |
|
—— | histamine dichloride | 56-92-8 | C5H11N3*2Cl |
|
—— | (2E)-3-phenyl-N-[2,2,2-trichloro-1-[[(8-quinolylamino)thiomethyl]amino]ethyl]-2-acrylamide | 405060-95-9 | C21H17Cl3N4OS |
|
—— | romidepsin | 128517-07-7 | C24H36N4O6S2 |
|
—— | [7-[cis-3-[(Azetidin-1-yl)methyl]cyclobutyl]-5-(3-benzyloxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amine | 475489-16-8 | C27H29N5O |
|
—— | 2-[4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-yl)phenyl]cyclohexyl]acetic acid | 1109276-89-2 | C21H24N4O4 |
|
—— | (+)-Dimethindene | 121367-05-3 | C20H24N2 |
|
—— | AM211 | 1175526-27-8 | C27H27F3N2O4 |
|
—— | Azilsartan medoxomil | 863031-21-4 | C30H24N4O8 |
|
—— | Cilomilast | 153259-65-5 | C20H25NO4 |
|
—— | cilomilast | 153259-65-5 | C20H25NO4 |
|
—— | 1,1'-[1,4-phenylene-bis(methylene)]-bis(1,4,8,11-tetra-azacyclotetradecane) octahydrochloride | 155148-31-5 | C28H54N8*8ClH |
|
—— | cyclosporin A | 59865-13-3 | C62H111N11O12 |
|
—— | cyclosporine A | 59865-13-3 | C62H111N11O12 |
|
—— | (2S,4S,5S,7S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl]octanamide hemifumarate | 173334-58-2 | C4H4O4*2C30H53N3O6 |
|
—— | 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide | 2171019-55-7 | C26H32N6O |
|
—— | fluzoparib | 1358715-18-0 | C22H16F4N6O2 |
|
—— | N-(6-(4-(5-amino-1,3,4-thiadiazol-2-yl)butyl)pyridazin-3-yl)-2-(3-trifluoromethoxyphenyl)acetamide | 1439399-45-7 | C19H19F3N6O2S |
|
—— | reboxetine mesylate | 98769-84-7 | CH4O3S*C19H23NO3 |
|
—— | nebivolol hydrochloride | 152520-56-4 | C22H25F2NO4*ClH |
|
—— | N-benzoylstaurosporine | 120685-11-2 | C35H30N4O4 |
|
—— | 4'-N-benzoyl staurosprine | 120685-11-2 | C35H30N4O4 |
|
—— | 2-cyano-3-(3,4-dihydroxyphenyl)-N-(2-phenylethyl)prop-2-enamide | 134036-52-5 | C18H16N2O3 |
|
—— | [4-(Cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate | 850876-88-9 | C35H46FN5O9S |
|
—— | [6-[[12-[3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-(1-hydroxyethyl)-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate | 873857-62-6 | C52H74Cl2O18 |
|
—— | N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacosan-16-yl)-2-hydroxy-2-[2-hydroxy-6-methyl-5-(2-methylbutyl)oxan-2-yl]propanamide | 125228-51-5 | C38H64N8O13 |
|
—— | 6,9-Difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione | 2135-17-3 | C22H28F2O5 |
|
—— | N-[25-(1-azabicyclo[2.2.2]octan-3-ylsulfanylmethyl)-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide | 120138-50-3 | C53H67N9O10S |
|
—— | Methyl 11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate | 218600-53-4 | C32H43NO4 |
|
—— | N<sup>2'</sup>-deacetyl-N-<sup>2’</sup>(N-methylalanyl)maytansine | 35846-53-8 | C34H46ClN3O10 |
|
—— | 7-[2-(1,1-Difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid | 136790-76-6 | C20H32F2O5 |
|
—— | GSKJ4 | 1373423-53-0 | C24H27N5O2 |
|
—— | 17β-<3-Cyclopentyl-propionyloxy>-Δ<sup>1,3,5(10)</sup>-oestratrienol-(3) | 313-06-4 | C26H36O3 |
|
—— | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | 65673-63-4 | C17H17BrN2O5 |
|
—— | 4-(1H-imidazol-5-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-10,12,14-triene-3,6-dione | 58735-64-1 | C22H23N5O2 |
|
—— | 3ξ-hydroxy-(5ξ)-androstan-17-one | 53-41-8 | C19H30O2 |
|